Here, we characterize SEMA4D expression in neurodegenerative disease settings of HD and AD, and report SEMA4D-induced changes in cytoskeletal morphology and regulation of key receptors and enzymes required for normal astrocytic functions in glucose metabolism and neurotransmitter recycling. Here, SEMA4D is linked to Alzheimer disease.